VOLTA

VOLTA - Validation Of Model-Based Therapy Decision Support in Hematology

Due to rapid advances in medical and pharmacological research, physicians today have increasingly effective options for the treatment of cancer. However, as the appropriate drugs are increasingly tailored to the specific characteristics of the patient and disease, new challenges arise in taking into account the complex diagnostic data and available therapeutic information (e.g. clinical trials). Since 2020, the Innovation Center Computer Assisted Surgery (ICCAS) at Leipzig University Medical Center, together with the Clinic for Hematology, Cell Therapy and Hemostaseology at Leipzig University Hospital, has been developing the IT platform “KAIT” – a comprehensive system for the analysis of medical information, which is intended to support the process of therapy decision-making in the clinical picture of multiple myeloma in the long term. The aim is to provide the treating physicians with all the latest information on the available therapeutic options so that every decision can be made on the basis of the latest findings. This will make an important contribution to the treatment of myeloma patients in Germany, regardless of where they receive medical care. Within the VOLTA project, this new and innovative form of clinical assistance will be further developed and extensively tested and optimized with clinical experts. These measures will ensure that “KAIT” can make a reliable and safe contribution to everyday clinical practice in the long term.